NEW YORK (GenomeWeb) – Molecular diagnostics company CareDx has selected DNAnexus' cloud-based bioinformatics infrastructure to handle data from its proprietary next-generation sequencing-based cell-free DNA transplant assay, which is scheduled for release later this year.

DNAnexus' platform will also support ongoing research and development activities at CareDx as well as the company's clinical trials and registries, the partners said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Sponsored by

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.